327 event(s) found
PSCC Summer Science Summit - Latest breakthroughs in Immuno-Oncology
The Paris-Saclay Cancer Cluster (PSCC) will host a highly exclusive gathering in immuno-oncology in France. On this summer day, a constellation of the world’s most influential immunologists — including a Nobel Laureate and the pioneers who transformed immune checkpoint therapy — will share one stage at Campus Grand Parc in Villejuif. These are the scientists who decoded immune checkpoints, redefined tissue-resident immunity, reshaped myeloid biology, and opened entirely new therapeutic frontiers in cancer. On one stage, you will hear from: · James Allison (MD Anderson Cancer Center) · Florent Ginhoux (Gustave Roussy) · Matteo Iannacone (Ospedale San Raffaele) · Alan Korman (BlueSphere Bio) · Matthew Krummel (UCSF) · Laura Mackay (Doherty Institute) · Miriam Merad (Icahn School of Medecine at Mount Sinaï) · Shalin Naik (Walter & Eliza Hall Institute of Medical Research (WEHI) ) · Pam Sharma (MD Anderson Cancer Center) · Eric Vivier (CIML) · Laurence Zitvogel (Gustave Roussy) Bringing them together - on one stage, in one day - is rare. Experiencing it will be even rarer. Note: Due to a very high number of registrations, in-person attendance is limited and subject to confirmation.
MASCC/ISOO 2026 Annual Meeting
The MASCC/ISOO Annual Meeting is the leading international, interdisciplinary event dedicated to supportive cancer care. Our 2026 theme—Coordinated and Individualized Supportive Cancer Care—reflects our commitment to advancing care that is both evidence-based and patient-centered. Jo Bowen This year’s program will spotlight three key areas: “Mind the Gap”: Maximizing Access to Supportive Care for All Addressing disparities in supportive care for underserved communities, including those in rural and remote areas; gender and sexually diverse populations; culturally and linguistically diverse groups; older adults; individuals of lower socioeconomic status; those in low- and middle-income countries; and First Nations Peoples. Lifestyle and Behavioral Support in Cancer Care Exploring the role of exercise, nutrition, integrative medicine, psychotherapy, and digital health technologies in enhancing care during and after treatment. Optimizing Toxicity Management of Novel Therapies Focusing on the prediction, assessment, and management of toxicities associated with emerging cancer treatments. In addition to these focus areas, the program will feature a broad range of sessions led by MASCC/ISOO study groups, covering topics that address the full spectrum of challenges faced by patients during and after treatment. The meeting offers excellent opportunities for networking, collaboration, and the chance to present your own research to a global audience. Social events will showcase Melbourne’s vibrant food, arts, and sports scenes—making the meeting both enriching and memorable.
ASCO Breakthrough 2026
ASCO Breakthrough 2026 organized by ASCO
Board Review: XX Curso de Revisão em Hematologia e Hemoterapia
O Board Review de Hematologia é um dos mais tradicionais e respeitados Eventos de educação médica continuada na América Latina. Em sua 20ª edição, de 2026, o encontro reuniu especialistas nacionais e internacionais para discutir os avanços mais recentes em leucemias, mieloma, linfomas, transplante de medula, terapia celular, SMD/NMP e outras áreas da hematologia moderna. Conheça alguns destaques que fazem do BOARD REVIEW: XX Curso de Revisão em Hematologia e Hemoterapia: · XII Simpósio Multidisciplinar em Hematologia, Hemoterapia e Transplante de Medula Óssea · X Simpósio de Atualizações em Oncologia Pediátrica · VIII Simpósio Multidisciplinar em Oncologia Pediátrica · IV Encontro de Gerenciamento de dados e Terapia Celular
Ninth JCA-AACR Special Joint Conference on Novel Therapies and Diagnostics in Upper Digestive and Head and Neck Cancers
The Japanese Cancer Association (JCA) and the AACR are proud to jointly present this Ninth JCA-AACR Special Joint Conference. This international collaboration will convene leading basic scientists and clinical researchers from around the world to share cutting-edge discoveries and emerging diagnostic and therapeutic opportunities in upper digestive and head and neck cancers. The conference will foster dynamic scientific exchange and collaboration, offering ample opportunities for meaningful discussions and interactions that are essential to advancing both basic research and clinical progress in the field. Sessions will also offer slots for proffered talks selected from highly rated abstract submissions.
ANZUP ASM 2026
ANZUP ASM 2026 organized by ANZUP
21st Biennial Congress of the MRS
The meeting will attract speakers from around the world to discuss the latest advances in research on metastatic cancers. The event will host a Networking Social at the Natural History Museum of Utah on the evening of Tuesday 30th June.
ESMO Gastrointestinal Cancers Congress 2026
The ESMO Gastrointestinal Cancers Congress 2026 will take place from 1 to 4 July in Munich, Germany, as well as online, through a dedicated virtual platform. This key meeting will gather world-renowned specialists, clinical researchers, and medical professionals who are at the forefront of progress in the prevention, diagnosis, and treatment of gastrointestinal cancers. With an engaging scientific agenda that includes expert-led discussions, multidisciplinary tumour boards, debates on clinical controversies, and cutting-edge research presentations, participants will gain valuable insights into the evolving landscape of GI oncology. Topics will span the full continuum of care, from early detection and biomarker-driven therapies to innovations in systemic treatment and patient quality of life. Designed to foster knowledge exchange and collaboration, the congress offers numerous opportunities to connect with peers, discuss real-world challenges, and share perspectives on advancing GI cancer care. Be part of this influential gathering to drive change, shape clinical practice, and help improve outcomes for patients worldwide.
Pancreatic Cancer Conference 2026
This conference will bring together an international, multidisciplinary community to showcase the latest in scientific advances, ignite meaningful debate and enable new collaborations to catalyse progress in pancreatic cancer research. The programme will feature speakers from across the globe in scientific sessions and panel discussions, with talks spanning discovery, translational and clinical science. Themes range from examining the basic biology of the exposome and its role in tumour initiation and progression to unpicking the systemic physiological disruptions of late-stage disease. This is a must-attend event for anyone working in pancreatic cancer research or related disciplines and is open to researchers from all career stages from across the world. There will be poster sessions and extensive networking opportunities for early career researchers.
Tumour Microenvironment meeting and 3D Cancer Modelling workshop
Building on the success of four previous tumour microenvironment meetings, we will again showcase fantastic international tumour microenvironment research.
2026 Best of ASCO® Philadelphia
Total Health's 2026 Best of ASCO® Philadelphia Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.
Best of ASCO Phoenix (Scottsdale) 2026
Best of ASCO®, an Official Annual Meeting Review of the American Society of Clinical Oncology® (ASCO®), is a two-day program designed to provide the latest science and education from the world’s premier oncology event, the ASCO® Annual Meeting. The abstracts selected for presentation and discussion reflect the foremost research and strategies in oncology that will impact clinical practice and patient care. The program features in-depth discussion and analysis of the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment. Expert faculty will review the findings, discuss the results potential impact on the current standard of care, and apply the results within the clinical context of a patient case.
AACR Special Conference in Cancer Research: Breaking Barriers in the Fight Against Rare Cancers
Conference on breakthroughs and collaborative strategies targeting rare cancers.
Molecular Biology in Clinical Oncology Workshop
An intensive workshop providing a substantive overview of molecular biology, translational cancer research, current lab techniques, career development, and the best practices of grant writing for the aspiring physician-scientist.
Integrative Molecular Epidemiology Workshop: Bridging Cancer Biology and Precision Medicine
The AACR Integrative Molecular Epidemiology Workshop is a transformative, week-long program designed to advance the skills of early-career researchers in molecular cancer epidemiology. With over 400 researchers trained since its inception, this workshop bridges the gaps between genetics, molecular markers, exposures, and advanced molecular methods. It fosters collaboration across disciplines such as epidemiology, bioinformatics, biostatistics, and molecular biology. Participants will gain hands-on experience in refining study designs, integrating omics technologies, geospatial data, and epidemiological methods to uncover insights into cancer etiology, prevention, and outcomes. The workshop emphasizes practical applications of cutting-edge tools while focusing on reproducibility, study feasibility, and quality control. Researchers will also engage in discussions on overcoming barriers to ensure that all benefit from advances in cancer research. Designed for emerging molecular epidemiologists, clinicians, statisticians, bioinformaticians, and researchers from allied fields, the workshop cultivates both technical expertise and a collaborative, forward-thinking mindset. Continuing to shape the future of cancer research, this workshop plays a key role in developing a diverse, skilled biomedical workforce. Join us to connect theoretical knowledge with real-world applications, advancing cancer research through team science and interdisciplinary collaboration.
2026 Pan Pacific Lymphoma Conference
The TAP Meetings listing includes hematologic oncology conferences focused on translational advances and clinical research in blood cancers, highlighting international collaboration and innovation.
AACR Drug Discovery and Development (AACR D3)
This groundbreaking global conference will redefine the future of oncology drug development by challenging conventional paradigms and catalyzing innovation across disciplines. Bringing together a diverse and influential community—including leaders from biotech, pharma, academia, regulatory agencies, technology, venture capital, and patient advocacy—this conference is being launched to spark bold ideas and foster transformative collaborations. Far beyond traditional didactic sessions, the conference will feature immersive and interactive formats to create dynamic networking opportunities and facilitate real-time problem-solving. Attendees will explore cutting-edge science, novel technologies, and emerging frameworks that promise to revolutionize how cancer therapies are discovered, developed, and delivered.
Joint Educational Program on Multiple Myeloma - ABHH, IMS & GBRAM
In Portuguese: "Temos grande satisfação em convidá-los para este encontro dedicado ao mieloma múltiplo. Este evento foi pensado como um espaço de atualização científica, discussão de avanços recentes e troca de experiências entre especialistas da área. Será uma oportunidade valiosa para compartilhar conhecimentos, debater desafios da prática clínica e fortalecer a colaboração entre profissionais comprometidos com o cuidado aos pacientes. Esperamos contar com a sua presença para tornar este encontro ainda mais enriquecedor. Inscrições serão abertas em breve! Target Audience: Médicos hematologistas e hemoterapeutas, médicos residentes e profissionais da área da saúde"
2026 SUO Resident Course
More information coming soon...
VI Conferência Internacional de Atualizações em Onco-hematologia e Terapia Celular
In Portuguese: "A Conferência Internacional de Atualizações em Onco-hematologia e Terapia Celular visa trazer o que há de mais novo nestas áreas, que tem tido grande avanço científico nos últimos anos. Tem como objetivo promover a exposição e o debate de temas, além de incentivar a interação entre os participantes e os palestrantes."
AACR/ASCO Methods in Clinical Cancer Research Workshop
The AACR/ASCO Methods in Clinical Cancer Research Workshop is an intensive workshop in the essentials of effective clinical trial designs of therapeutic interventions in the treatment of cancer for clinical fellow and junior faculty clinical researchers in all oncology subspecialties, including radiation, surgical oncology, and radiology.
SNO/ASCO CNS Metastases Conference
The Society for Neuro-Oncology (SNO), in collaboration with the American Society of Clinical Oncology (ASCO), present this year’s SNO/ASCO CNS Metastases Conference. The theme is From Moonshot to Groundshot: Transforming Science into Impact, and the scientific content of this dynamic event includes outstanding keynote and plenary addresses on the complex and rapidly evolving area of CNS metastases. The program is interdisciplinary, intentionally structured to connect discovery to clinical impact across the continuum of brain and leptomeningeal metastasis care. Sessions will address basic, translational, and clinical research defining CNS tropism and the metastatic microenvironment, highlighting advances in multidisciplinary treatment strategies, including precision neurosurgery, modern radiotherapy techniques such as stereotactic radiosurgery and FLASH, and the rational integration of systemic therapies. The agenda further examines topics which underscore the progression from scientific moonshots to ground-level changes in patient care. In addition, the latest work shown in selected scientific abstracts will be highlighted in oral presentations and the poster networking reception. Conference topics will include: · CNS-active targeted agents and immunotherapies · device-based local therapies; tumor-treating fields · management of acute and long-term treatment-related toxicities · patient quality of life and survivorship · data-driven decision-making
IFHNOS 8th World Congress 2026
We are very excited to invite you to the 8th IFHNOS World Congress to be held in Brisbane, Australia, in August 2026, in collaboration with the Australian and New Zealand Head and Neck Cancer Society. The theme of the congress is “Global Harmonisation of Head and Neck Cancer Care”. IFHNOS is made up of over 70 member societies across 58 countries, and so this will truly be an engaging international head and neck cancer conference for the ages. Along with the organising team, we plan to deliver an exciting 4 days of a high quality scientific and social program. We hope to welcome you to Brisbane in August 2026!
ELRIG’s Scottish Forum:Translational medicine for womens health
More information coming soon…